Tesi etd-09242012-000122 |
Link copiato negli appunti
Tipo di tesi
Tesi di laurea magistrale
Autore
CHIRICHELLA, MICHELE
Indirizzo email
michele.chirichella@hotmail.it
URN
etd-09242012-000122
Titolo
In vivo selection of intrabodies for post-translational protein targeting
Dipartimento
BIOLOGIA
Corso di studi
BIOLOGIA MOLECOLARE E CELLULARE
Relatori
relatore Prof. Cattaneo, Antonino
controrelatore Prof. Andreazzoli, Massimiliano
controrelatore Prof.ssa Dente, Luciana
controrelatore Prof. Andreazzoli, Massimiliano
controrelatore Prof.ssa Dente, Luciana
Parole chiave
- antibody
- bait
- intrabodies
- post-translational modification
- protein silencing
- protein targeting
- PTM
- scFv
- single domain antibodies
- yeast two-hybrid
Data inizio appello
18/10/2012
Consultabilità
Non consultabile
Data di rilascio
18/10/2052
Riassunto
Intracellular Antibodies (Intrabodies) are engineered antibodies (or antibody domains) ectopically expressed in several cell types to specifically perturb the function of intracellular antigens. (Biocca & Cattaneo, 1995)
Since Antibodies are proteins whose folding depends on the formation of critical disulphide bonds, the successful recognition of the physiological target, located in a reducing environment such as the cytoplasm, is somewhat unpredictable.
For this reason, a general and reliable method for the intracellular selection of Intrabodies was developed (Visintin et al, 1999). Based on the two-hybrid assay in yeast, the so-called “IACT” (Intracellular Antibody Capture Technology) allows us to isolate specific intrabodies, from diverse cDNA libraries of antibody domains [either ScFv (Single Chain Fragment Variable domains) or dAbs (single domain antibodies)] directly in the cytosolic environment, avoiding any protein manipulation and solving the folding problem.
Since Antibodies are proteins whose folding depends on the formation of critical disulphide bonds, the successful recognition of the physiological target, located in a reducing environment such as the cytoplasm, is somewhat unpredictable.
For this reason, a general and reliable method for the intracellular selection of Intrabodies was developed (Visintin et al, 1999). Based on the two-hybrid assay in yeast, the so-called “IACT” (Intracellular Antibody Capture Technology) allows us to isolate specific intrabodies, from diverse cDNA libraries of antibody domains [either ScFv (Single Chain Fragment Variable domains) or dAbs (single domain antibodies)] directly in the cytosolic environment, avoiding any protein manipulation and solving the folding problem.
File
Nome file | Dimensione |
---|---|
La tesi non è consultabile. |